Matches in SemOpenAlex for { <https://semopenalex.org/work/W2035609519> ?p ?o ?g. }
- W2035609519 endingPage "121" @default.
- W2035609519 startingPage "117" @default.
- W2035609519 abstract "A phase II multi-institutional clinical trial conducted to evaluate the efficacy and tolerability of docetaxel and carboplatin as first-line therapy for women with metastatic breast cancer.Patients had histologically confirmed metastatic breast cancer with at least one measurable lesion. Prior adjuvant chemotherapy was permitted, provided that at least 12 months had elapsed between any prior taxane and platinum therapy. Patients received docetaxel 75 mg/m(2) with carboplatin AUC 6 mg/ml.min every 21 days until disease progression or prohibitive toxicity.All 53 patients enrolled were evaluable for response and toxicity. Median number of cycles delivered was 6. Overall response rate was 60%, with 3 complete responses (6%) and 29 partial responses (54%). Median time to disease progression was 9.6 months. Median survival time was 20.4 months. Myelosuppression was the predominant toxicity, with grade 3 or 4 neutropenia occurring in 94% of patients and 15% of patients experiencing febrile neutropenia. The overall incidence (grades 1-3) of neurosensory toxicity was 57% and neuromotor toxicity was 25%, respectively, with grade 3 toxicity occurring in 4% of patients each.The combination of docetaxel and carboplatin is highly active in metastatic breast cancer. Prophylactic growth factor support is recommended in any further evaluation of this combination in the treatment of patients with breast cancer." @default.
- W2035609519 created "2016-06-24" @default.
- W2035609519 creator A5012465182 @default.
- W2035609519 creator A5018883411 @default.
- W2035609519 creator A5021192497 @default.
- W2035609519 creator A5024191700 @default.
- W2035609519 creator A5029941846 @default.
- W2035609519 creator A5040261194 @default.
- W2035609519 creator A5065306642 @default.
- W2035609519 creator A5068091055 @default.
- W2035609519 creator A5082661564 @default.
- W2035609519 creator A5083904553 @default.
- W2035609519 date "2005-01-01" @default.
- W2035609519 modified "2023-10-17" @default.
- W2035609519 title "A Phase II Trial of Docetaxel and Carboplatin as First-Line Chemotherapy for Metastatic Breast Cancer: NCCTG Study N9932" @default.
- W2035609519 cites W1854164300 @default.
- W2035609519 cites W1940165440 @default.
- W2035609519 cites W1955744924 @default.
- W2035609519 cites W2025356866 @default.
- W2035609519 cites W2045701290 @default.
- W2035609519 cites W2092087181 @default.
- W2035609519 cites W2106427904 @default.
- W2035609519 cites W2114886993 @default.
- W2035609519 cites W2139248078 @default.
- W2035609519 cites W2141429974 @default.
- W2035609519 cites W2247434504 @default.
- W2035609519 cites W4293241248 @default.
- W2035609519 doi "https://doi.org/10.1159/000087813" @default.
- W2035609519 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16118507" @default.
- W2035609519 hasPublicationYear "2005" @default.
- W2035609519 type Work @default.
- W2035609519 sameAs 2035609519 @default.
- W2035609519 citedByCount "17" @default.
- W2035609519 countsByYear W20356095192013 @default.
- W2035609519 countsByYear W20356095192014 @default.
- W2035609519 countsByYear W20356095192016 @default.
- W2035609519 countsByYear W20356095192018 @default.
- W2035609519 countsByYear W20356095192020 @default.
- W2035609519 countsByYear W20356095192021 @default.
- W2035609519 countsByYear W20356095192022 @default.
- W2035609519 crossrefType "journal-article" @default.
- W2035609519 hasAuthorship W2035609519A5012465182 @default.
- W2035609519 hasAuthorship W2035609519A5018883411 @default.
- W2035609519 hasAuthorship W2035609519A5021192497 @default.
- W2035609519 hasAuthorship W2035609519A5024191700 @default.
- W2035609519 hasAuthorship W2035609519A5029941846 @default.
- W2035609519 hasAuthorship W2035609519A5040261194 @default.
- W2035609519 hasAuthorship W2035609519A5065306642 @default.
- W2035609519 hasAuthorship W2035609519A5068091055 @default.
- W2035609519 hasAuthorship W2035609519A5082661564 @default.
- W2035609519 hasAuthorship W2035609519A5083904553 @default.
- W2035609519 hasConcept C121608353 @default.
- W2035609519 hasConcept C126322002 @default.
- W2035609519 hasConcept C141071460 @default.
- W2035609519 hasConcept C143998085 @default.
- W2035609519 hasConcept C197934379 @default.
- W2035609519 hasConcept C2775930923 @default.
- W2035609519 hasConcept C2776694085 @default.
- W2035609519 hasConcept C2777063308 @default.
- W2035609519 hasConcept C2777511904 @default.
- W2035609519 hasConcept C2778239845 @default.
- W2035609519 hasConcept C2778375690 @default.
- W2035609519 hasConcept C2778850193 @default.
- W2035609519 hasConcept C2781190966 @default.
- W2035609519 hasConcept C2781451048 @default.
- W2035609519 hasConcept C29730261 @default.
- W2035609519 hasConcept C530470458 @default.
- W2035609519 hasConcept C71924100 @default.
- W2035609519 hasConceptScore W2035609519C121608353 @default.
- W2035609519 hasConceptScore W2035609519C126322002 @default.
- W2035609519 hasConceptScore W2035609519C141071460 @default.
- W2035609519 hasConceptScore W2035609519C143998085 @default.
- W2035609519 hasConceptScore W2035609519C197934379 @default.
- W2035609519 hasConceptScore W2035609519C2775930923 @default.
- W2035609519 hasConceptScore W2035609519C2776694085 @default.
- W2035609519 hasConceptScore W2035609519C2777063308 @default.
- W2035609519 hasConceptScore W2035609519C2777511904 @default.
- W2035609519 hasConceptScore W2035609519C2778239845 @default.
- W2035609519 hasConceptScore W2035609519C2778375690 @default.
- W2035609519 hasConceptScore W2035609519C2778850193 @default.
- W2035609519 hasConceptScore W2035609519C2781190966 @default.
- W2035609519 hasConceptScore W2035609519C2781451048 @default.
- W2035609519 hasConceptScore W2035609519C29730261 @default.
- W2035609519 hasConceptScore W2035609519C530470458 @default.
- W2035609519 hasConceptScore W2035609519C71924100 @default.
- W2035609519 hasIssue "2" @default.
- W2035609519 hasLocation W20356095191 @default.
- W2035609519 hasLocation W20356095192 @default.
- W2035609519 hasOpenAccess W2035609519 @default.
- W2035609519 hasPrimaryLocation W20356095191 @default.
- W2035609519 hasRelatedWork W1982849070 @default.
- W2035609519 hasRelatedWork W1987090710 @default.
- W2035609519 hasRelatedWork W1988843825 @default.
- W2035609519 hasRelatedWork W1991613108 @default.
- W2035609519 hasRelatedWork W2035609519 @default.
- W2035609519 hasRelatedWork W2095756161 @default.
- W2035609519 hasRelatedWork W2111487955 @default.
- W2035609519 hasRelatedWork W2129979963 @default.